The importance of ophthalmology and optometry working together to transform care for patients with conditions such as cataracts and glaucoma will come under the spotlight at 100% Optical. NHS ophthalmology provider Newmedica is hosting a series of continuing professional development...
Case report A 16-year-old Caucasian male was referred to the eye casualty at Nottingham University Hospitals NHS Trust by the infectious diseases unit in September 2013. He gave a history of photophobia, pain on eye movements and central blurred vision...
One of the lovely things about clinical meetings and conferences is the ability to meet with your peers and ask questions of them about their practice. Often the questions are not earth shattering, for example, it could be as simple...
Once again, I am grateful for the responses and read the results with interest. I am always surprised by the amount of practice variation I see. I fully accept there is art in what we do and there is no...
Europe: from the Greek eurus: broad, wide, and ops: eye, face, sight. Thus Europe = the far-sighted (lady). For my first contribution to this column – as the successor of Jonathan Park, whose witty observations and entertaining style many of...
The North of England Ophthalmological Society (NEOS) Summer Meeting 2025 was convened by Lawrence Gnanaraj, Consultant Paediatric Ophthalmologist at the Sunderland Eye Infirmary. The opening morning programme was titled ‘Is Small a Big Problem?’ and addressed a wide range of...
It has been estimated that one billion people globally live with visual impairment. Moreover, countries in the developing world are disproportionately affected, with four times more low vision than compared to countries with well-established systems of primary, secondary and tertiary...
Dolby Laboratories and Royal National Institute of Blind People (RNIB) have reimagined the world’s most famous artwork masterpieces - from Da Vinci’s Mona Lisa to David Hockney’s A Bigger Splash - to create an immersive soundtrack, in state-of-the-art Dolby Atmos...
A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.